These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12804401)

  • 1. Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment.
    Walters EH; Walters J
    Cochrane Database Syst Rev; 2003; (2):CD001285. PubMed ID: 12804401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.
    Walters EH; Walters J
    Cochrane Database Syst Rev; 2000; 2003(4):CD001285. PubMed ID: 11034709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled long acting beta agonists for stable chronic asthma.
    Walters EH; Walters JA; Gibson MD
    Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.
    Walters EH; Walters JA; Gibson PW
    Cochrane Database Syst Rev; 2002; 2002(4):CD003901. PubMed ID: 12519616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Shah L; Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
    Sestini P; Renzoni E; Robinson S; Poole P; Ram FS
    Cochrane Database Syst Rev; 2002; (4):CD001495. PubMed ID: 12519559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
    Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous beta2-agonists for acute asthma in the emergency department.
    Travers A; Jones AP; Kelly K; Barker SJ; Camargo CA; Rowe BH
    Cochrane Database Syst Rev; 2001; 2001(2):CD002988. PubMed ID: 11406055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
    Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006924. PubMed ID: 19370661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2000; (2):CD001281. PubMed ID: 10796631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta₂-agonists for exercise-induced asthma.
    Bonini M; Di Mambro C; Calderon MA; Compalati E; Schünemann H; Durham S; Canonica GW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003564. PubMed ID: 24089311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.
    Spooner CH; Spooner GR; Rowe BH
    Cochrane Database Syst Rev; 2003; 2003(4):CD002307. PubMed ID: 14583951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.